Institutes / Research Units

Diabetes Research

Institute of Diabetes Research (IDF)

Director: Prof. Dr. Anette-Gabriele Ziegler

Chair of Diabetes and Gestational Diabetes at Technische Universität München

The Institute of Diabetes Research (IDF) researches the pathogenesis and prevention of type 1 diabetes and gestational diabetes. To this end, it investigates the molecular mechanisms leading to the development of the disease, in particular the interaction of environment, genes and immune system. The aim of this research is to identify markers for early diagnosis and to develop treatments for the prevention and cure of diabetes. IDF is a part of the Helmholtz Diabetes Center (HDC).

To the IDF website
To the HDC website

Institute for Diabetes Research and Metabolic Diseases (IDM)

Director: Prof. Dr. Dr. h.c. Hans Ulrich Häring

Medical director of Medical Clinic IV at the University Hospital Tübingen

The primary research objective of the Institute of Diabetes Research and Metabolic Diseases (IDM) of Helmholtz Zentrum München at the University of Tübingen is the individualized prediction of diabetes risk, diabetes prevention and the personalized treatment of diabetes. The main research focus is on gene-environment interaction in type 2 diabetes. IDM is a part of the Helmholtz Diabetes Center (HDC).


To the HDC website

Institute of Diabetes and Obesity (IDO)

Director: Prof. Dr. Matthias Tschöp

Chair of Diabetes Research / Insulin Resistance at Technische Universität München

The Institute of Diabetes and Obesity (IDO) studies the metabolic syndrome by means of systems biological and translational approaches, using cell-based systems, genetically modified mouse models and clinical intervention studies. The aim of this research is to discover new signaling pathways in order to develop innovative interdisciplinary approaches for the personalized prevention and treatment of obesity, diabetes and concomitant diseases. IDO is a part of the Helmholtz Diabetes Center (HDC).

To the IDO website
To the HDC website

Diabetes- and Regeneration Research (IDR)

Director: Prof. Dr. Heiko Lickert

Chair of Diabetes Research / Beta Cell Biology at Technische Universität München

The Institute of Diabetes and Regeneration Research (IDR) researches the biology and regeneration of the pancreas, especially the insulin-producing beta cells. The primary aim is to enable regenerative therapy approaches for the treatment of diabetes mellitus and thus to provide alternatives to traditional therapy approaches. The IDR seks to discover novel drugs that enhance beta cell differentiation and function and is working towards a beta cell replacement therapy. IDR is a part of the Helmholtz Diabetes Center (HDC).

To the IDR website
To the HDC website

Institute of Experimental Genetics (IEG)

Director: Prof. Dr. Martin Hrabě de Angelis

Chair of Experimental Genetics at Technische Universität München

The aim of the Institute of Experimental Genetics (IEG) is to further the basic understanding of mechanisms that underlie the etiology of human diseases, in particular for diabetes and other metabolic diseases as well as bone/cartilage disorders. Experimental set-ups are centered on the mouse as pre-clinical model organism. Besides studying the effects of genotypes, the IEG is researching the effects of environmental factors on the etiology of diseases. The German Mouse Clinic (GMC) researches these aspects at a systemic level. IEG is a part of the Helmholtz Diabetes Center (HDC). The IEG includes the Genome Analysis Center (GAC).

To the IEG website
To the GAC website
To the HDC website

Research Unit Genome Analysis Center (GAC)

Head: Prof. Dr. Jerzy Adamski


The Genome Analysis Center (GAC) is part of the Institute of Experimental Genetics (IEG). It aims to provide scientists with a state-of-the-art infrastructure for gene analyses on a large scale and for the application of OMICS technologies.  

To the GAC website
To the IEG website

Lung Biology and Allergy Research

Institute of Lung Biology and Diseases/ Comprehensive Pneumology Center (CPC)

Director: Prof. Dr. Oliver Eickelberg

Chair of Experimental Pneumology at Ludwig Maximilians Universität Munich

Chronic lung diseases are the research focus of the Institute of Lung Biology and Diseases (iLBD) and of the Comprehensive Pneumology Center (CPC). The aim of this research are novel approaches to diagnostics or therapy. To this end, scientists strive to elucidate the underlying mechanisms of diseases such as chronic obstructive pulmonary disease (COPD), lung fibrosis, lung cancer or asthma and complications following lung transplantation (bronchiolitis obliterans) and translate them into therapeutic approaches for patients.

To the CPC website

Institute of Allergy Research (IAF)

Director: Prof. Dr. Carsten Schmidt-Weber

Chair of Molecular Allergology and Environmental Research at Technische Universität München

The Institute of Allergy Research (IAF) researches mechanisms responsible for the development of allergies and the build-up of allergy tolerance in the context of genetic predisposition, immune system and environmental factors. In cooperation with the Center of Allergy & Environment, the institute conducts basic and basic clinical research. The aim is to understand the diseases, assess risks, intervene preventatively and to treat these diseases successfully.

To the IAF website

Genetics and Stem Cell Biology

Institute of Human Genetics (IHG)

Director: Prof. Dr. Thomas Meitinger

Chair of Human Genetics at Technische Universität München

The identification and functional characterization of genes related to disease are at the heart of research carried out at the Institute of Human Genetics (IHG). Mapping techniques are applied in search of disease associated gene variants. Research groups focus on cardiovascular disorders, neurological disorders and energy metabolism disorders. The aim of this research is to achieve a better understanding of the genetic basis of multifactorial diseases.

To the IHG website

Institute of Stem Cell Research (ISF)

Director: Prof. Dr. Magdalena Götz

Chair of Physiological Genomics at Ludwig Maximilians Universität Munich

The Institute of Stem Cell Research (ISF) investigates the basic molecular and cellular mechanisms for stem cell maintenance and stem cell differentiation. On this basis, the ISF develops approaches for the replacement of degenerated cell types, either by activation of endogenous stem cells or by re-programming other endogenous cells for repair. The aim of these approaches is the self-renewal of injured or degenerated tissue.

To the ISF website

Research Unit Stem Cell Dynamics (SCD)

Head: Dr. Timm Schroeder


The independent Research Unit Stem Cell Dynamics (SCD) investigates the lifelong regeneration of organs by means of stem cells and progenitor cells. The research unit analyzes the molecular control of stem cell behavior of different types of tissue, in particular the blood system, using bioimaging procedures. The aim of this research is to achieve a better understand the underlying mechanisms of stem cell control, and ultimately the development of new stem cell based procedures for clinical application.

To the SCD website

Research Unit Sensory Biology and Organogenesis (SBO)

Head: Dr. Hernán López-Schier


The independent Research Unit Sensory Biology and Organogenesis (SBO) investigates cellular, molecular and physiological reactions to mechanical stimuli and sensory disorders, using the zebra fish as a model system. The main focus is on the physical and mechanical properties of the tissue. The aim of this research is to investigate the mechanisms controlling the development, self-regulation and regeneration of the sensory system as well as the evolution of the sensory organs for the perception of the environment.

To the SBO website

Institute of Developmental Genetics (IDG)

Director: Prof. Dr. Wolfgang Wurst

Chair of Developmental Genetics at Technische Universität München

The Institute of Developmental Genetics (IDG) focuses on the functional analysis of the mammalian genomes, the development of methods for such analysis and on the development of animal models for the analysis of the genome and the study of the pathogenesis of human diseases. The aim of this research is to investigate genetically determined diseases of the central nervous systems, the eye, and the skeletal system, and to elucidate the molecular mechanisms that control embryonal development.

To the IDG website

Research Unit Comparative Medicine (AVM)

Head: PD Dr. Markus Brielmeier


The independent Research Unit Comparative Medicine (AVM) is a central service platform and as such ensures state-of-the-art breeding and husbandry of laboratory animals according to scientific and legal standards.  The unit’s scientific work focuses on hygiene and microbiology of laboratory animals, animal welfare and reproduction biology as well as animal models for human diseases. The unit trains specialist veterinarians and scientists as well as laboratory technicians and animal keepers, focusing on research and translation into therapeutic approaches.

To the AVM website

Epidemiology and Health Economics

Institute of Epidemiology I (EPI I)

Director (acting): Dr. Joachim Heinrich


The Institute of Epidemiology I (EPI I) investigates environmental and lifestyle factors, genetic constitution and metabolic processes for the onset and the progression of respiratory diseases, metabolic diseases and allergic diseases, as well as selected cancers. To this end, the institute uses data and biosamples from the cohorts GINI, LISA and MONICA/KORA. The institute has assumed a key role in planning and implementing the National Cohort.

To the EPI I website

Institute of Epidemiology II (EPI II)

Director: Prof. Dr. Annette Peters


The Institute of Epidemiology II (EPI II) researches the correlation between environment, lifestyle, and genetics and in etiology of diabetes, cardiac diseases and successful ageing. The institute’s research builds on the unique KORA resources (cohort, myocardial infarction register, aerosol measurement station). Follow-up studies within the cohort allow for an assessment of intermediate phenotypes of selected chronic diseases and associated complications as well as their incidence.

To the EPI II website

Institute of Genetic Epidemiology (IGE)

Director: Prof. Dr. Konstantin Strauch

Chair of Genetic Epidemiology at Ludwig Maximilians Universität Munich

The Institute of Genetic Epidemiology (IGE) deals with genetic statistics. This comprises planning, realization and analysis of genetic-epidemiological projects of complex diseases as well as on the development and implementation of new statistical methods. The focus of the institute’s work is on diseases that are assessed in the context of the population-based KORA cohort. The aim of the institute is to contribute to the elucidation of genetic causes of complex diseases.

To the IGE website

Research Unit Molecular Epidemiology (AME)

Head (acting): Prof. Dr. Annette Peters


The independent Research Unit Molecular Epidemiology (AME) analyses population-based chohorts and case studies for certain diseases, using genomics, epigenomics, transcriptomics, proteomics, metabolomics and functional analyses. The aim of this research is to decipher the molecular mechanisms of complex diseases like type 2 diabetes or obesity. The unit administers the biological specimen repository of the Department of Epidemiology and stores the samples for national and international projects.

To the AME website

Health Economics and Health Care Management (IGM)

Director: Prof. Dr. Reiner Leidl

Chair of Health Economics and Health Care Management at Ludwig Maximilians Universität Munich

The Institute of Health Economics and Health Care Management (IGM) analyzes approaches to improve the effectiveness and efficiency of health care. Using empirical methods, economic, socioeconomic and management issues are investigated at the level of health systems, of medical technologies and of care strategies.

To the IGM website

Radiation Research

Research Unit Medical Radiation Physics and Diagnostics (AMSD)

Head: Prof. Dr. Christoph Hoeschen


The independent Research Unit Medical Radiation Physics and Diagnostics (AMSD) develops and improves methods to capture and reduce the exposure of humans in medical diagnostics. In the field of imaging diagnostics, the unit develops procedures to assure image quality and reduce the dosage. The aim of this research is to optimize and personalize technologies for medical radiation diagnostics and therapy, and to reduce radiation damage. The AMSD is part of the Department of Radiation Sciences (DRS).


To the AMSD website
To the DRS website

Institute of Radiation Biology (ISB)

Director: Prof. Dr. Michael Atkinson

Chair of Radiation Biology at Technische Universität München

Using molecular and cell biological techniques, the Institute of Radiation Biology (ISB) researches the complex cellular reactions after exposure to radiation.  The focus is on analyzing the effects of low dose radiation exposure and on studies to increase the effectiveness and specificity of tumor radiotherapy. This research is conducted by four interlinked research groups. ISB is a part of the Department of Radiation Sciences (DRS).

To the ISB website
To the DRS website

Institute of Radiation Protection (ISS)

Director (acting): Dr. Peter Jacob


The Institute of Radiation Protection (ISS) focuses on the measurement and evaluation of occupational, medical and environmental radiation exposure, analyses related risks of cancer and cardiovascular diseases and organizes training courses in radiation protection. The institute’s aim is to achieve a better understanding of the effects of radiation, using innovative procedures, and to optimize the safe use of radiation in industry and medicine. ISS is a part of the Department of Radiation Sciences (DRS).


To the ISS website
To the Education and Training website (German only)
To the DRS website

Research Unit Radiation Cytogenetics (ZYTO)

Head: Prof. Dr. Horst Zitzelsberger


The independent Research Unit Radiation Cytogenetics (ZYTO) investigates radiation induced chromosome and DNA damage in cell systems and human tumors. The focus is on the elucidation of mechanisms associated with radiation-induced carcinogenesis and radiation sensitivity of tumor cells. The aim of this research is to find biomarkers associated with radiation-induced tumors to develop personalized radiation therapy for the stratification of patients. ZYTO is a part of the Department of Radiation Sciences (DRS).

To the ZYTO website
To the DRS website

Systems Biology, Imaging and Structural Biology

Institute of Structural Biology (STB)

Director: Prof. Dr. Michael Sattler

Chair of Biomolecular NMR Spectroscopy at Technische Universität München

The Institute of Structural Biology (STB) investigates the spatial structures of biological macromolecules, analyses the interplay between the structure and dynamics and develops NMR spectroscopy techniques for a structural analyses of complex biomolecular systems.  The aim of this research is to elucidate the biological function of molecules and their involvement in diseases and to apply structural data as a basis for the design and development of small molecule inhibitors in combination with chemical biology approaches.

To the STB website

Institute of Biological and Medical Imaging (IBMI)

Director: Prof. Dr. Vasilis Ntziachristos

Chair of Biological Imaging at Technische Universität München

The Institute of Biological and Medical Imaging (IBMI) researches in vivo imaging technologies for biosciences. It develops systems, theories and methods for imaging and image reconstruction as well as animal models for the interrogation of new technologies at the biological, pre-clinical and clinical level. The aim of this research is to provide innovative tools for the biomedical laboratory, for diagnostics and disease monitoring and for the treatment of human diseases.

To the IBMI website

Institute of Bioinformatics and Systems Biology (IBIS)

Director: Prof. Dr. Werner Mewes

Chair of Genome-Oriented Bioinformatics at Technische Universität München

The Institute of Bioinformatics and Systems Biology (IBIS) analyses and interprets biological data in order to capture information on the etiology and progression of human diseases in rational models. The institute’s workgroups focus on qualitative and quantitative modeling, on the interconnection of metabolic profiles with genetic variance, on the systematic interpretation of high throughput data and on the systems biology of small molecules.

To the IBIS website

Institute of Computational Biology (ICB)

Director: Prof. Dr. Dr. Fabian Theis


The Institute of Computational Biology develops and applies methods for the model-based description of biological systems, using a data-driven approach by integrating information on multiple scales ranging from single-cell time series to large-scale omics. Given the fast technological advances in molecular biology, their aim is to provide and collaboratively apply innovative tools with experimental groups in order to jointly advance our understanding and treatment of common human diseases.


To the ICB website
To the ASC website

- Research Unit Scientific Computing (ASC)

Head: PD Dr. Wolfgang zu Castell


The Research Unit Scientific Computing (ASC) is a part of the Institute of Computational Biology and as such combines the organization of the central data center of Helmholtz Zentrum München with research componentes in scientific computing. The aim of the research unit is the provision of ICT serves for all institutes and research units of Helmholtz Zentrum München and to develop and apply mathematical methods for computational analysis and simulation of biological system.

To the ASC website
To the ICB website

Research Unit Protein Science (PROT)

Head: Prof. Dr. Marius Ueffing

Chair of Experimental Ophthalmology at the University of Tübingen

The independent Research Unit Protein Science (PROT) investigates the composition of protein complexes and their integration into cellular processes and protein networks. One research focus is the analysis of the cooperation of genetic variance and environmental factors in the field of neurodegenerative and metabolic diseases. The aim of this research is to identify biological systems and their specific disease-related disorders on a systematic level, thus contributing to a molecular understanding of diseases.

To the PROT website

Infection and Immune Biology

Institute of Pathology (PATH)

Director: Prof. Dr. Heinz Höfler

Chair of General Pathology and Pathological Anatomy at Technische Universität München

The Institute of Pathology (PATH) identifies and characterizes biological changes in cancer cells in order to predict whether tumors are likely to respond to treatment. The aim of this research is to develop innovative, individualized therapy protocols for tumors. Mouse pathology presents an important interface between genetic changes and the distinct phenotype.
PATH includes the Research Unit Analytical Pathology (AAP) with its state-of-the-art infrastructure and histopathological expertise.

To the PATH website
To the AAP website

- Research Unit Analytical Pathology (AAP)

Head: Prof. Dr. Axel Walch


The Research Unit Analytical Pathology (AAP) is a part of the Institute of Pathology. It pools state-of-the-art infrastructure such as mass spectronomy imaging and histopathological expertise.

To the AAP website

Institute of Molecular Toxicology and Pharmacology (TOXI)

Director: Prof. Dr. Martin Göttlicher

Chair of Toxicology and Environmental Hygiene at Technische Universität München

The Institute of Molecular Toxicology and Pharmacology (TOXI) investigates the cellular response pathways and genetic foundations with which the organism reacts to chemical substances.. The aim of this research is to achieve a better understanding of  the role of these mechanisms in the etiology and progression of complex diseases and to reduce health risks. This leads to the development of approaches for the prevention of environmentally related diseases and for innovative therapeutic concepts. TOXI includes the Research Unit Cellular Signal Integration (AZS).

To the TOXI website
To the AZS website

- Research Unit Cellular Signal Integration (AZS)

Head: Dr. Daniel Krappmann


The Research Unit Cellular Signal Integration (AZS) at the Institute of Molecular Toxicology and Pharmacology (TOXI)  conducts research for a better understanding of cellular response pathways. In doing so, it focuses on the interaction of proteins complexes and the effects of posttranslational modifications. The aim of this research is to understand the faulty regulation of the signal complexes in the immune system in case of infectious diseases and the development of lymphoma, and to attack this pharmacologically.

To the AZS website
To the TOXI website

Institute of Clinical Molecular Biology and Tumor Genetics (KMOLBI)

Director (acting): Prof. Dr. Wolfgang Hammerschmidt


The Institute of Clinical Molecular Biology and Tumor Genetics (KMOLBI) investigates genetic alterations that arise in cells during malignant transformation and are causally related to the development into tumor cells. The aim of this research is to go beyond basic research and make advances in the therapy of malignant diseases as well as developing vectors for gene therapy. KMOLBI includes the Research Unit Molecular Epigenetics (MEG).

To the KMOLBI website
To the MEG website

- Research Unit Molecular Epigenetics (MEG)

Head: Prof. Dr. Dirk Eick


The Research Unit Molecular Epigenetics (MEG) researches basic epigenetic mechanisms of gene regulation, thus creating the basis for a better understanding of the role of epigenetics in the etiology of diseases. MEG is a part of the Institute of Clinical Molecular Biology and Tumor Genetics (KMOLBI).

To the MEG website
To the KMOLBI website

Institute of Molecular Immunology (IMI)

Acting Director: Prof. Dr. Ralph Mocikat


The Institute of Molecular Immunology (IMI) conducts application-oriented basic research at the boundary between hematology, immunology, oncology and transplantation biology. This is where concepts are developed for modulating the immune system by means of cell and molecular biological methods. Using a simulation of the immune system, patient benefit could be derived by investigating new strategies for immunotherapy and gene therapy for cancer, autoimmune diseases and graft rejections. The IMI includes the Immune Monitoring Platform, the Monoclonal Antibodies Platform and the Research Unit Molecular Immune Regulation (AMIR).

To the IMI website
To the AMIR website

Research Unit Molecular Immunoregulation (AMIR)

Head: Dr. Vigo Heissmeyer


The Reserarch Unit Molecular Immunoregulation (AMIR), headed up by Dr. Vigo Heissmeyer, is part of the Institute of Molecular Immunology. AMIR investigates the molecular programming of T-cell tolerance, inter alia at the level of posttranscriptional gene regulation. The aim of AMIR is to achieve a better understanding of the molecular programs of T-cells, which make a distinction between the body’s own structure and foreign structures possible. The research focus is on autoimmune diseases such as type 1 diabetes and Lupus erythematodes.

To the AMIR website
To the IMI website

Institute of Virology (VIRO)

Director: Prof. Dr. Ulrike Protzer

Chair of Virology at Technische Universität München

The Institute of Virology (VIRO) investigates viruses that can cause chronic infections life-threatening diseases in humans. The research focus is on the AIDS virus (HIV), on endogenous retroviruses that are integrated into our germline, and on hepatitis B and C viruses, which cause liver cirrhosis and hepatocellular carcinoma.  Molecular studies identify new diagnostic and therapeutic concepts to prevent and treat these viral diseases or to prevent the development of virus-induced tumors.

Homepage VIRO

Research Unit Gene Vectors (AGV)

Head: Prof. Dr. Wolfgang Hammerschmidt


The independent Research Unit Gene Vectors (AGV) investigates the Epstein Barr Virus (EBV) and its interaction with human B-cells, in particular in the infection and transformation of the target cells to tumor cells or cells, which proliferate indefinitely. The aim of this research is to achieve a detailed understanding of the EBV infection in the development of tumors and to put these insights to medical use in the shape of a unique model system.

To the AGV website

Ecosystems Biology

Institute of Biochemical Plant Pathology (BIOP)

Director: Prof. Dr. Jörg Durner

Chair of Biochemical Plant Pathology at Technische Universität München

The Institute of Biochemical Plant Pathology (BIOP) explores defense mechanisms, growth and fitness of plants in response to environmental cues, with a focus on molecular mechanisms that allow plants to respond to biotic and abiotic factors. The aim of this research is to find new procedures for sustainable agriculture and biotechnological use of plants, as well as to contribute to safeguarding the role of plants in the nourishment and health of human beings.
BIOP is a part of the Department of Environmental Sciences (DES). BIOP includes the Research Unit Environmental Engineering (EUS).

To the BIOP website
To the EUS website
To the DES website

Comprehensive Molecular Analytics (CMA)

Head: Prof. Dr. Ralf Zimmermann

Zur CMA-Website
Zur DES-Website

- Research Unit Environmental Simulation (EUS)

Head: Prof. Dr. Jörg-Peter Schnitzler


The Research Unit Environmental Simulation (EUS) is a part of the Institute of Biochemical Plant Pathology. It pools infrastructure and expertise for researching the influence of the global climate change on growth, yield and health of crops and energy plants, as well as on biodiversity.  EUS offer environmental simulation at the highest level and state-of-the-art methods of eco physiology and mass spectroscopy. Its research focuses on the biosphere-atmosphere exchange of biogenic volatile organic compounds.

To the EUS website
To the BIOP website

Institute of Soil Ecology (IBOE)

Director: Prof. Dr. Jean Charles Munch

Chair of Soil Ecology at Technische Universität München

The Institute of Soil Ecology (IBOE) records, forecasts and evaluates structural changes and biotic processes in the soil, caused by humans or by the climate change. The aim of this research is to investigate the effects of land use and of new atmospheric conditions on the soil as a biotope and on the nutrient cycle controlled by the soil, and its effects on other areas of the environment such as the atmosphere or waters, and to derive alternative action plans. IBOE is a part of the Department of Environmental Sciences (DES).

To the IBOE website
To the DES website

Institute of Groundwater Ecology (IGOE)

Director: Prof. Dr. Rainer Meckenstock

Chair of Groundwater Ecology at Technische Universität München

The Institute of Groundwater Ecology (IGOE) focuses on the processes of self-cleaning and the transport of harmful substances in groundwater and develops ecological assessment criteria for groundwater ecosystems. The principal aim is to research the microbial processes that lead to self-cleaning of groundwater and thus contribute to preserving our most important source of drinking water. IGOE is a part of the Department of Environmental Sciences (DES).

To the IGOE website
To the DES website

Research Unit Microbe-Plant Interactions (AMP)

Head: Prof. Dr. Anton Hartmann


The independent Research Unit Microbe-Plant Interactions (AMP) investigates the molecular mechanisms of semiochemicals between bacteria and plants in the root area, but also in the interaction between animals and humans. The aim of this research is to understand these semiochemicals as important control factors of the interaction between human-pathogenic and probiotic bacteria with their hosts (plants, animals, humans) and to find a way to put them to practical use. AMP is a part of the Department of Environmental Sciences (DRS).

To the AMP website
To the DES website

Research Unit BioGeoChemistry and Analytics (BGC)

Head: PD Dr. Philippe Schmitt-Kopplin


The independent Research Unit Analytical BioGeoChemistry (BGC) investigates molecular interactions of substances in biogeo systems. High-resolution methods in the elucidation of organic structures, in conjunction with separation sciences and mathematical methods, allow for a precise space and time-resolved analysis. The aim of this research is to achieve a better understanding of the molecular processes in ecosystems and to improve the identification of biomarkers in organisms.  BGC is a part of the Department of Environmental Sciences (DES).

To the BGC website
To the DES website

Research Unit Environmental Genomics (EGEN)

Head: Prof. Dr. Michael Schloter


The independent Research Unit Environmental Genomics (EGEN) investigates the structure and function of microbial communities in the soil and identifies abiotic and biotic parameters, which control abundance, diversity and activity of the corresponding microbiomes. The aim of this research is to make the genetic resources of the soil microflora better usable for a sustainable bio economy. EGEN is a part of the Department of Environmental Sciences (DES).

To the EGEN website
To the DES website

Research Unit Plant Genome and Systems Biology (PGSB)

Head: Dr. Klaus Mayer

The main focus of the independent Research Unit Plant Genome and Systems Biology (PGSB) is plant genome and systems-oriented bioinformatics. It has a focus towards analyzing genomic encryption, expression patterns, functional and systems biology of plants. PGSB also maintains a large data set of plant genomes in databases, which it makes available to the public along with comparative analyses.

To the PGSB website
To the DES website